Endostatin mutants with mutations at ATP binding sites

• 收藏
• 分享

专利权人:

Tsinghua University;Beijing Protgen LTD.

发明人:

Luo, Yongzhang,Liu, Peng,Lu, Xinan,Chen, Yang,Fu, Yan,Chang, Guodong,Zhou, Daifu

申请号：

AU2012306826

公开号：

AU2012306826B2

申请日:

2012.09.10

申请国别(地区):

AU

年份:

2018

代理人:

摘要：

Discloses is a new medication against tumors that comprises a vascular endothelial myostatin mutant. The mutant mutates at ATP binding sites, and has lowered ATPase activity and enhanced neovascular growth inhibition activity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/